Strikingly, our data from CLP mice suggest that treatment with IL‐38 can notably improve the survival rate of septic mice and confirm that CD4+CD25+Tregs are required for the beneficial effects of IL‐38 in the development of sepsis. Here, IL1F10 is linked to Sepsis.